Respiratory

New research highlights the significant impact of Respiratory Syncytial Virus (RSV) vaccines in reducing severe respiratory illness among older adults, a group disproportionately affected by RSV.

Ensifentrine, an innovative dual bronchodilator and anti-inflammatory medication, has shown promising results in reducing healthcare usage among patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Critical insights into outpatient antibiotic use and treatment failure rates among U.S. children diagnosed with pneumonia, underscoring significant gaps in care, have been revealed in a new study.

A significant increase in walking pneumonia cases among children, largely attributed to Mycoplasma pneumoniae infections, is drawing attention from U.S. healthcare professionals.

A reported rise in respiratory infections has been issued by the U.S. CDC, particularly Mycoplasma pneumonia and RSV.

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.

A nationwide study presented at the CHEST Annual Meeting 2024 revealed rising trends in metabolically healthy obesity (MHO) among elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease

A strong link has been identified between the cumulative impact of neighborhood-level environmental and social factors, known as the “neighborhood exposome,” and the prevalence of asthma and COPD in U.S. adults